Previous Article | Next Article 
Infection and Immunity, March 2001, p. 1889-1894, Vol. 69, No. 3
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.3.1889-1894.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Tumor Necrosis Factor Alpha Increases Human
Cerebral Endothelial Cell Gb3 and Sensitivity to
Shiga Toxin
Patricia B.
Eisenhauer,1
Prasoon
Chaturvedi,2
Richard E.
Fine,1
Andrew J.
Ritchie,3
Jordan S.
Pober,4
Thomas G.
Cleary,5 and
David S.
Newburg2,*
Bedford VA Medical Center, Bedford, and Boston University,
Boston,1 Shriver Center for Mental Retardation,
Waltham, and Harvard Medical School,
Boston,2 and Brigham and Women's
Hospital, Boston,3 Massachusetts;
Yale Medical School, New Haven,
Connecticut4; and University of Texas
Medical School, Houston, Texas5
Received 26 July 2000/Returned for modification 6 September
2000/Accepted 6 December 2000
Hemolytic uremic syndrome (HUS) is associated with intestinal
infection by enterohemorrhagic Escherichia coli strains
that produce Shiga toxins. Globotriaosylceramide (Gb3) is
the functional receptor for Shiga toxin, and tumor necrosis factor
alpha (TNF-
) upregulates Gb3 in both human macrovascular
umbilical vein endothelial cells and human microvascular brain
endothelial cells. TNF-
treatment enhanced Shiga toxin binding
and sensitivity to toxin. This upregulation was specific for
Gb3 species containing normal fatty acids (NFA). Central
nervous system (CNS) pathology in HUS could involve cytokine-stimulated elevation of endothelial NFA-Gb3 levels. Differential
expression of Gb3 species may be a critical determinant of
Shiga toxin toxicity and of CNS involvement in HUS.
*
Corresponding author. Mailing address: Shriver Center,
200 Trapelo Rd., Waltham, MA 02452. Phone: (781) 642-0025. Fax:
(781) 893-4018. E-mail: dnewburg{at}shriver.org.
Infection and Immunity, March 2001, p. 1889-1894, Vol. 69, No. 3
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.3.1889-1894.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Stone, M. K., Kolling, G. L., Lindner, M. H., Obrig, T. G.
(2008). p38 Mitogen-Activated Protein Kinase Mediates Lipopolysaccharide and Tumor Necrosis Factor Alpha Induction of Shiga Toxin 2 Sensitivity in Human Umbilical Vein Endothelial Cells. Infect. Immun.
76: 1115-1121
[Abstract]
[Full Text]
-
Nolasco, L. H., Turner, N. A., Bernardo, A., Tao, Z., Cleary, T. G., Dong, J.-f., Moake, J. L.
(2005). Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers. Blood
106: 4199-4209
[Abstract]
[Full Text]
-
Guessous, F., Marcinkiewicz, M., Polanowska-Grabowska, R., Kongkhum, S., Heatherly, D., Obrig, T., Gear, A. R. L.
(2005). Shiga Toxin 2 and Lipopolysaccharide Induce Human Microvascular Endothelial Cells To Release Chemokines and Factors That Stimulate Platelet Function. Infect. Immun.
73: 8306-8316
[Abstract]
[Full Text]
-
Viebig, N. K., Wulbrand, U., Forster, R., Andrews, K. T., Lanzer, M., Knolle, P. A.
(2005). Direct Activation of Human Endothelial Cells by Plasmodium falciparum-Infected Erythrocytes. Infect. Immun.
73: 3271-3277
[Abstract]
[Full Text]
-
Pohlenz, J. F., Winter, K. R., Dean-Nystrom, E. A.
(2005). Shiga-Toxigenic Escherichia coli-Inoculated Neonatal Piglets Develop Kidney Lesions That Are Comparable to Those in Humans with Hemolytic-Uremic Syndrome. Infect. Immun.
73: 612-616
[Abstract]
[Full Text]
-
Bitzan, M., Bickford, B. B., Foster, G. H.
(2004). Verotoxin (Shiga Toxin) Sensitizes Renal Epithelial Cells to Increased Heme Toxicity: Possible Implications for the Hemolytic Uremic Syndrome. J. Am. Soc. Nephrol.
15: 2334-2343
[Abstract]
[Full Text]
-
Harrison, L. M., van Haaften, W. C. E., Tesh, V. L.
(2004). Regulation of Proinflammatory Cytokine Expression by Shiga Toxin 1 and/or Lipopolysaccharides in the Human Monocytic Cell Line THP-1. Infect. Immun.
72: 2618-2627
[Abstract]
[Full Text]
-
Yoshida, T., Sugiyama, T., Koide, N., Mori, I., Yokochi, T.
(2003). Human microvascular endothelial cells resist Shiga toxins by IFN-{gamma} treatment in vitro. Microbiology
149: 2609-2614
[Abstract]
[Full Text]
-
Imai, Y., Fukui, T., Kurohane, K., Miyamoto, D., Suzuki, Y., Ishikawa, T., Ono, Y., Miyake, M.
(2003). Restricted Expression of Shiga Toxin Binding Sites on Mucosal Epithelium of Mouse Distal Colon. Infect. Immun.
71: 985-990
[Abstract]
[Full Text]
-
Erwert, R. D., Winn, R. K., Harlan, J. M., Bannerman, D. D.
(2002). Shiga-like Toxin Inhibition of FLICE-like Inhibitory Protein Expression Sensitizes Endothelial Cells to Bacterial Lipopolysaccharide-induced Apoptosis. J. Biol. Chem.
277: 40567-40574
[Abstract]
[Full Text]
-
Hughes, A. K., Ergonul, Z., Stricklett, P. K., Kohan, D. E.
(2002). Molecular Basis for High Renal Cell Sensitivity to the Cytotoxic Effects of Shigatoxin-1: Upregulation of Globotriaosylceramide Expression. J. Am. Soc. Nephrol.
13: 2239-2245
[Abstract]
[Full Text]
-
Moake, J. L.
(2002). Thrombotic Microangiopathies. NEJM
347: 589-600
[Full Text]